NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins.

Recs

0
Player Avatar PDTBiotech (95.80) Submitted: 7/4/2012 11:35:47 PM : Outperform Start Price: $9.00 NPSP Score: +49.27

Attractive target for anyone with a GI sales force.

Featured Broker Partners


Advertisement